Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as a promising cell-free therapeutic strategy in regenerative medicine and immunomodulation. These nanosized vesicles, carrying bioactive molecules like miRNAs, proteins, and lipids, exhibit dual capabilities in regulating immune responses and promoting tissue repair. MSC-EVs promote tissue regeneration, including revascularization, skeletal and dental tissue repair, wound healing, hepatic and renal regeneration, and neural repair. Simultaneously, their immunomodulatory properties-suppressing excessive inflammation and regulating immune cell activity, make them promising interventions for autoimmune, neurodegenerative, and inflammatory conditions. By integrating tissue repair with immune regulation, MSC-EVs represent a transformative paradigm in precision therapeutics, meriting accelerated clinical exploration.